The expression of SFTPB decreased significantly by 1.44-fold in the mild group compared to the asymptomatic COVID-19-positive patient group (p = 0.0482) and by 1.73-fold in the severe group compared to the mild group (p = 0.0120). Here, SFTPB is linked to COVID-19.